Advanced search
Publication Cover
Leukemia & Lymphoma Volume 61, 2020 - Issue 8
Submit an article Journal homepage
212
Views
5
CrossRef citations to date
0
Altmetric
Letters to the Editor

Detection of an IGH-BRAF fusion in a patient with BRAF Val600Glu negative hairy cell leukemia

Ella R. ThompsonDepartment of Pathology, Peter MacCallum Cancer Centre, Melbourne, Australia; ;Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; Correspondence[email protected]
,
Kenneth J.C. LimDepartment of Haematology, St Vincent’s Hospital, Melbourne, Australia;
,
James A. KuzichDepartment of Pathology, Peter MacCallum Cancer Centre, Melbourne, Australia;
,
Michelle McBeanDepartment of Pathology, Peter MacCallum Cancer Centre, Melbourne, Australia;
,
David WestermanDepartment of Pathology, Peter MacCallum Cancer Centre, Melbourne, Australia; ;Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; ;Clinical Haematology, Peter MacCallum Cancer Centre/Royal Melbourne Hospital, Melbourne, Australia;
,
Constantine S. TamDepartment of Haematology, St Vincent’s Hospital, Melbourne, Australia; ;Clinical Haematology, Peter MacCallum Cancer Centre/Royal Melbourne Hospital, Melbourne, Australia; ;Department of Medicine, University of Melbourne, Melbourne, Australia
&
Piers BlomberyDepartment of Pathology, Peter MacCallum Cancer Centre, Melbourne, Australia; ;Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; ;Clinical Haematology, Peter MacCallum Cancer Centre/Royal Melbourne Hospital, Melbourne, Australia;
show all
Pages 2024-2026 | Received 12 Feb 2020, Accepted 30 Mar 2020, Published online: 22 Apr 2020

References

  • Tiacci E, Trifonov V, Schiavoni G, et al. BRAF mutations in hairy-cell leukemia. N Engl J Med. 2011;364(24):2305–2315.
  • Tschernitz S, Flossbach L, Bonengel M, et al. Alternative BRAF mutations in BRAF V600E-negative hairy cell leukaemias. Br J Haematol. 2014;165(4):529–533.
  • Tiacci E, Pettirossi V, Schiavoni G, et al. Genomics of hairy cell leukemia. JCO. 2017;35(9):1002–1010.
  • Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th edn. Lyon, France: International Agency for Research on Cancer; 2017.
  • Hockley SL, Giannouli S, Morilla A, et al. Insight into the molecular pathogenesis of hairy cell leukaemia, hairy cell leukaemia variant and splenic marginal zone lymphoma, provided by the analysis of their IGH rearrangements and somatic hypermutation patterns. Br J Haematol. 2010;148(4):666–669.
  • Tiacci E, Liso A, Piris M, et al. Evolving concepts in the pathogenesis of hairy-cell leukaemia. Nat Rev Cancer. 2006;6(6):437–448.
  • Ryland GL, Jones K, Chin M, et al. Novel genomic findings in multiple myeloma identified through routine diagnostic sequencing. J Clin Pathol. 2018;71(10):895–899.
  • Kerkhoff E, Rapp UR. Cell cycle targets of Ras/Raf signalling. Oncogene. 1998;17(11):1457–1462.
  • Holderfield M, Deuker MM, McCormick F, et al. Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond. Nat Rev Cancer. 2014;14(7):455–467.
  • Ciampi R, Knauf JA, Kerler R, et al. Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer. J Clin Invest. 2005;115(1):94–101.
  • Palanisamy N, Ateeq B, Kalyana-Sundaram S, et al. Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma. Nat Med. 2010;16(7):793–798.
  • Ross JS, Wang K, Chmielecki J, et al. The distribution of BRAF gene fusions in solid tumors and response to targeted therapy. Int J Cancer. 2016;138(4):881–890.
  • Chakraborty R, Burke TM, Hampton OA, et al. Alternative genetic mechanisms of BRAF activation in Langerhans cell histiocytosis. Blood. 2016;128(21):2533–2537.
  • Zarnegar S, Durham BH, Khattar P, et al. Novel activating BRAF fusion identifies a recurrent alternative mechanism for ERK activation in pediatric Langerhans cell histiocytosis. Pediatr Blood Cancer. 2018;65(1):e26699.
  • Diamond EL, Durham BH, Haroche J, et al. Diverse and targetable kinase alterations drive histiocytic neoplasms. Cancer Discov. 2016;6(2):154–165.
  • Morgan GJ, He J, Tytarenko R, et al. Kinase domain activation through gene rearrangement in multiple myeloma. Leukemia. 2018;32(11):2435–2444.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.